PGP and colon carcinoma: As colorectal tumours are known to exhibit high levels of the P-gp protein (Fojo et al, 1987) and are intrinsically resistant to drugs involved in MDR it could be interesting to investigate whether a resistance modifying effect of rhein exists in human P-gp overexpressing colon carcinomas.